P-glycoprotein--a mediator of multidrug resistance in tumour cells.
about
Modulation of paclitaxel resistance by annexin IV in human cancer cell linesReversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell lineSmall and Innovative Molecules as New Strategy to Revert MDRMode of binding of anti-P-glycoprotein antibody MRK-16 to its antigen. A crystallographic and molecular modeling studyP-glycoprotein increases the efflux of the androgen dihydrotestosterone and reduces androgen responsive gene activity in prostate tumor cellsCarbamazepine is not a substrate for P-glycoproteinCharacterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiologyCyclosporin analogs inhibit in vitro growth of Cryptosporidium parvum.Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelateBIRB796, the inhibitor of p38 mitogen-activated protein kinase, enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cellsA novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathwayIn vitro activity of rifampicin and verapamil combination in multidrug-resistant mycobacterium tuberculosisAnthrapyridones, a novel group of antitumour non-cross resistant anthraquinone analogues. Synthesis and molecular basis of the cytotoxic activity towards K562/DOX cells.Doxycycline induces expression of P glycoprotein in MCF-7 breast carcinoma cellsStimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site.Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression.HPMA copolymers: origins, early developments, present, and future.Ligand-mediated tertiary structure changes of reconstituted P-glycoprotein. A tryptophan fluorescence quenching analysis.Regulation of volume-activated chloride channels by P-glycoprotein: phosphorylation has the final say!A family of drug transporters: the multidrug resistance-associated proteins.Interaction of common azole antifungals with P glycoproteinMDR1 function is sensitive to the phosphorylation state of myosin regulatory light chainCharacterization of ABC transporter ABCB1 expressed in human neural stem/progenitor cells.Relevance of multidrug resistance proteins for intestinal drug absorption in vitro and in vivo.Doxorubicin pathways: pharmacodynamics and adverse effects.Farnesyl transferase inhibitors in the treatment of breast cancer.Toward an Ising model of cancer and beyondIntestinal absorption of novel-dipeptide prodrugs of saquinavir in rats.Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer.Synthesis and biological evaluation of a novel class of isatin analogs as dual inhibitors of tubulin polymerization and Akt pathwayMultidrug resistance proteins in rheumatoid arthritis, role in disease-modifying antirheumatic drug efficacy and inflammatory processes: an overview.Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression.Cellular delivery of doxorubicin via pH-controlled hydrazone linkage using multifunctional nano vehicle based on poly(β-l-malic acid)Single nucleotide polymorphisms in human P-glycoprotein: its impact on drug delivery and disposition.CpABC, a Cryptosporidium parvum ATP-binding cassette protein at the host-parasite boundary in intracellular stages.The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis.In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance.Phenytoin intoxication with no symptoms correlated with serum drug level: a case studyExtraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein.Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities.
P2860
Q24644209-003B1C37-48BB-4D5A-9E5C-0C7A77390316Q24800442-70035C45-F85E-4169-8918-05AA4489E486Q27012455-B8C41654-F12D-46BF-95B7-3DCDD9AF9F02Q27765326-2264DB04-EC48-4498-8405-A1CC55268DBAQ28167506-8FCD8197-7C60-48D4-976F-80EC5355C600Q28363548-751FAFC9-1DCB-4E24-9D27-A32851918829Q28379120-8F6150AF-BDAD-4517-A083-CAF76C342B47Q28379469-CA2B56E3-365D-4DF7-BBC7-A89F434EAAD4Q28474590-84174C0A-92E9-4F13-938F-F99B11EE828AQ28485188-44855375-4E15-497F-B873-30971E8082CCQ28487924-4C1BF246-3212-4A3B-871C-CC62996D5D36Q28543447-8102749D-DF67-4B01-AE47-A0AA1DA8941EQ30681104-724E1D70-7E4D-4C69-967C-FF2146EE788AQ31038995-6418EF41-12AE-4EFC-A1F7-73AAA2FA6120Q33177727-0BA0D6E4-9062-4143-B0FA-74D2C94679B5Q33482138-89F57918-926D-45A8-B89D-D276F4FCACC9Q33719148-D907F2FB-2009-4C8B-BD8F-8A17D4D68BD9Q33864499-50E4A79C-A7F2-4275-8FC5-6856BC225A6FQ33903142-72756501-994A-471A-8056-1D79D99EB576Q34004952-47E5143B-8A09-497C-90CA-80EFBC2A1CDEQ34104641-E284022E-54F2-4018-88D9-B1BB8C0003A0Q34198760-D4EDD70E-3338-4F3B-B58F-5315933871E1Q34425810-7EADD3A5-C61C-40B4-A8FE-7B6E359A0E99Q34634236-6FC091C9-6C82-4CED-A21E-1DD061FA4209Q35048393-3B8390AB-E0FE-4274-A7B6-FA594D4BD029Q35073354-88778EAB-B9B8-4443-91AF-EE719E6E4225Q35150426-0F7C7594-02D2-4275-ACC0-BF06DCAFCA9BQ35196290-39DB3783-A8F2-468F-AD67-B5B95D35A9B0Q35243396-CB38115E-DF56-4976-B56C-5F4966C8DB04Q35606342-052B48BA-4E1A-4789-A47B-B520C97CBAEEQ35744255-A947D679-FC2B-40AC-9129-B876A3C9D129Q36295007-B3591A46-9EDB-48A5-BFF5-D7A51C8CC157Q36321843-E0EE867B-3850-4888-9D08-AEC837441D7DQ36349672-0585E782-2F43-40AE-8DE7-EC2253F5F59AQ36367680-96ADEBEB-D6C1-4CC9-AF63-562562F83281Q36506556-D065A92B-E2B0-4131-B4D0-D9B80DE4D415Q36619418-A8FE582E-C975-4C60-96DF-C242AB43D833Q36624256-0F21FB28-A5C1-4988-9E79-7BA89160184BQ36895024-5F79D6EF-DD06-4295-8EEB-E75640162D90Q36895030-43ABE6C7-62DD-46CA-9D6B-C92F3F9F3F81
P2860
P-glycoprotein--a mediator of multidrug resistance in tumour cells.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
P-glycoprotein--a mediator of multidrug resistance in tumour cells.
@en
type
label
P-glycoprotein--a mediator of multidrug resistance in tumour cells.
@en
prefLabel
P-glycoprotein--a mediator of multidrug resistance in tumour cells.
@en
P1476
P-glycoprotein--a mediator of multidrug resistance in tumour cells.
@en
P2093
Germann UA
P304
P356
10.1016/0959-8049(96)00057-3
P577
1996-06-01T00:00:00Z